LSE - Delayed Quote USD

Masimo Corporation (0JZ2.L)

153.06

-3.89

(-2.48%)

At close: April 17 at 6:52:33 PM GMT+1

Why Masimo (MASI) Could Beat Earnings Estimates Again

Masimo (MASI) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Zacks yesterday

MASI
Why You Shouldn't Bet Against Masimo (MASI) Stock

Masimo (MASI) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.

Zacks 2 days ago

MASI
3 Healthcare Stocks Facing Headwinds

Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. But speed bumps such as inventory destockings have persisted in the wake of COVID-19, and over the past six months, the industry has pulled back by 14.8%. This performance was worse than the S&P 500’s 8.5% decline.

StockStory 3 days ago

MASI

LMAT

STE
A Look At The Intrinsic Value Of Masimo Corporation (NASDAQ:MASI)

Key Insights Masimo's estimated fair value is US$166 based on 2 Stage Free Cash Flow to Equity Current share price of...

Simply Wall St. 3 days ago

MASI
LFWD Stock Falls Despite Launch of Next-Generation Mobility ReWalk 7

Lifeward launches ReWalk 7 in the United States, offering advanced mobility, greater control and smarter walking for individuals with spinal cord injuries.

Zacks 3 days ago

ANGO

MASI

VEEV
Merit Medical Stock Slips Despite the Launch of New Ventrax System

MMSI launches the Ventrax Delivery System, enhancing pulmonary access procedures with improved control, precision, and efficiency for interventionalists.

Zacks 4 days ago

MMSI

MASI

VEEV
Here's Why Masimo (MASI) is a Strong Growth Stock

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Zacks 10 days ago

MASI
ICUI Stock Declines Despite Plans for Offsetting Tariff Impacts

ICU Medical unveils a strategic plan to offset new U.S. tariffs, aiming to protect margins and stability amid medtech market volatility and global trade shifts.

Zacks 10 days ago

ICUI

MASI
Q4 Patient Monitoring Earnings Review: First Prize Goes to Masimo (NASDAQ:MASI)

Let’s dig into the relative performance of Masimo (NASDAQ:MASI) and its peers as we unravel the now-completed Q4 patient monitoring earnings season.

StockStory 11 days ago

MASI

IRTC

DXCM
ZBH Stock to Gain From Volume Growth Amid Rising Costs

Zimmer Biomet is strategically expanding its global presence to address the huge demand in the musculoskeletal space.

Zacks 12 days ago

ZBH

MASI

BSX
GMED Stock May Benefit Following the Acquisition of Nevro

Globus Medical acquires Nevro Corp. to expand its presence in the $2.50 billion musculoskeletal market.

Zacks 12 days ago

GMED

NVRO

MASI
Medical Device Stocks Fall on Tariff Hit

President Trump’s tariffs will hit pacemakers, X-ray machines and other medical devices manufactured overseas and shipped to the U.S. Devices and diagnostic equipment are made all over the world, from China and Europe to Malaysia and Vietnam. Many manufacturers are well positioned to weather tariffs because patients will need to get their products, but Wells Fargo estimated companies’ annual earnings per share could take a hit as much as 13.8% in the case of Bausch & Lomb.

The Wall Street Journal 16 days ago

SEMHF

SMMNY

MDT
Q4 Earnings Highlights: iRhythm (NASDAQ:IRTC) Vs The Rest Of The Patient Monitoring Stocks

Looking back on patient monitoring stocks’ Q4 earnings, we examine this quarter’s best and worst performers, including iRhythm (NASDAQ:IRTC) and its peers.

StockStory 16 days ago

IRTC

DXCM

MASI
3 Stocks to Buy for "Liberation" From Trump Tariffs & Recession Woes

In 2025, companies like MASI, BSX and HIMS are expected to overcome challenges and sustain strong growth and market leadership.

Zacks 17 days ago

MASI

BSX
Masimo (MASI) is an Incredible Growth Stock: 3 Reasons Why

Masimo (MASI) is well positioned to outperform the market, as it exhibits above-average growth in financials.

Zacks 17 days ago

MASI
Masimo to Present in the 24th Annual Needham Virtual Healthcare Conference

IRVINE, Calif., April 02, 2025--Masimo (NASDAQ: MASI) today announced that its management will participate in the 24th Annual Needham Virtual Healthcare Conference on Wednesday, April 9, 2025 at 2:15 p.m. Eastern time. A live webcast of the presentation will be available on the Masimo website at www.masimo.com. A replay of the webcast will be available following the live presentation.

Business Wire 17 days ago

MASI
IceCure Medical Stock Dips Despite Positive ICESECRET Study Results

ICCM reports strong kidney cancer cryoablation study results, showcasing 88.7% recurrence-free rates and reinforcing its position in cryoablation technology.

Zacks 22 days ago

ICCM

MASI

BSX
International Expansion, Product Launches Support BSX Stock

Boston Scientific continues to successfully expand its operations across various geographies outside the United States.

Zacks 23 days ago

BSX

MASI

CAH
Masimo (MASI) Down 12.6% Since Last Earnings Report: Can It Rebound?

Masimo (MASI) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Zacks 23 days ago

MASI
Merit Medical Stock May Rise as WRAPSODY CIE Shows Strong Results

MMSI unveils 12-month efficacy data for WRAPSODY CIE, highlighting its advanced technology in vascular access maintenance and potential to improve patient outcomes.

Zacks 24 days ago

MMSI

MASI

CAH

Performance Overview

Return	0JZ2.L	MSCI WORLD (^990100-USD-STRD)
YTD	-9.91%	-6.25%
1-Year	+13.62%	+6.77%
3-Year	+11.67%	+16.08%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Masimo Corporation (0JZ2.L)

Why Masimo (MASI) Could Beat Earnings Estimates Again

Why You Shouldn't Bet Against Masimo (MASI) Stock

3 Healthcare Stocks Facing Headwinds

A Look At The Intrinsic Value Of Masimo Corporation (NASDAQ:MASI)

LFWD Stock Falls Despite Launch of Next-Generation Mobility ReWalk 7

Merit Medical Stock Slips Despite the Launch of New Ventrax System

Here's Why Masimo (MASI) is a Strong Growth Stock

ICUI Stock Declines Despite Plans for Offsetting Tariff Impacts

Q4 Patient Monitoring Earnings Review: First Prize Goes to Masimo (NASDAQ:MASI)

ZBH Stock to Gain From Volume Growth Amid Rising Costs

GMED Stock May Benefit Following the Acquisition of Nevro

Medical Device Stocks Fall on Tariff Hit

Q4 Earnings Highlights: iRhythm (NASDAQ:IRTC) Vs The Rest Of The Patient Monitoring Stocks

3 Stocks to Buy for "Liberation" From Trump Tariffs & Recession Woes

Masimo (MASI) is an Incredible Growth Stock: 3 Reasons Why

Masimo to Present in the 24th Annual Needham Virtual Healthcare Conference

IceCure Medical Stock Dips Despite Positive ICESECRET Study Results

International Expansion, Product Launches Support BSX Stock

Masimo (MASI) Down 12.6% Since Last Earnings Report: Can It Rebound?

Merit Medical Stock May Rise as WRAPSODY CIE Shows Strong Results

Performance Overview